Z-1790-2021 Class II Terminated
FDA device recall Z-1790-2021 was initiated by Terumo Cardiovascular Systems Corporation on April 16, 2021 and is designated Class II. Reason for recall: Terumo CVS has been unable to validate a cleaning protocol to satisfy current regulatory concerns and expectations. As a result, an updated cleaning protocol will not be developed by Terumo CVS and it… The recall status is terminated (terminated November 29, 2023). Affected quantity: 1176 devices.
Recall Details
- Product Type
- Devices
- Report Date
- June 9, 2021
- Initiation Date
- April 16, 2021
- Termination Date
- November 29, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1176 devices
Product Description
Reason for Recall
Distribution Pattern
Domestic: Foreign: Australia, Belgium, Canada, Chile, China, Colombia, Dominican Republic, England, France, Germany, Greece, Hong Kong, India, Indonesia, Iran, Israel, Italy, Japan, Korea, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Russia, Saudi Arabia, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UNITED ARAB EMIRATES (UAE), Vietnam